Related Experiment Video
Updated: Feb 6, 2026

Mining Spatial Transcriptomics Datasets using DeepSpaceDB
Published on: September 5, 2025
Spatial transcriptomics reveals tumor microenvironment-driven subtypes of invasive lobular carcinoma
Matteo Serra1, Mattia Rediti1,2, Laetitia Collet1
1Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels 1070, Belgium.
Abstract:
Invasive lobular carcinoma (ILC) is the second most common histological subtype of breast cancer and displays distinct clinical and biological behavior compared to breast cancer of no special type. However, current molecular classifications largely overlook its complex spatial organization and tumor microenvironment (TME). Here, we performed spatial transcriptomics on 43 hormone receptor-positive, HER2-negative (HR+/HER2-) ILC tumors with detailed morphological annotation and long-term clinical follow-up. By integrating spatial gene expression with histology and single-cell deconvolution, we characterized the composition and architecture of the TME and revealed high inter- and intratumor heterogeneity. Spatial clustering uncovered cell populations and pathways linked to clinical outcome. We then developed a multimodal classification of ILC by integrating gene expression, morphology, and spatial metrics, identifying four distinct subtypes: normal/stroma-enriched (NSE), proliferative (P), androgen receptor-enriched (ARE), and metabolic/immune-enriched (MIE). These subtypes, collectively termed ILC4TME, reflect the interplay between tumor and microenvironmental features. Gene signatures derived from the spatial data enabled subtype assignment in external bulk RNA-seq and microarray datasets (SCAN-B, METABRIC), revealing reproducible biology and significant associations with survival. In multivariable models, ILC4TME retained prognostic value beyond established gene signatures and clinicopathological variables. Notably, the P subtype was linked to poor prognosis, even in patients treated with endocrine therapy alone, while the NSE subtype was associated with favorable outcomes. Our findings uncover spatial and cellular heterogeneity in ILC that is not captured by existing classification approaches, offering a refined framework for risk stratification and therapeutic targeting based on tumor microenvironment architecture.
Related Concept Videos
The Tumor Microenvironment
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
ATP Driven Pumps I: An Overview
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
Xylem and Transpiration-driven Transport of Resources

